Dieldrin
|
CAS
60-57-1
|
C12H8Cl6O
|
RTECS
IO1750000
|
Synonyms & Trade Names
HEOD; 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4-endo,exo-5,8-dimethanonaphthalene
|
DOT ID & Guide
2761 / 151
|
Exposure
Limits
|
NIOSH REL: Ca TWA 0.25 mg/m3 [skin] See Appendix A
|
|
OSHA PEL: TWA 0.25 mg/m3 [skin]
|
IDLH
Ca [50 mg/m3]
See: 60571
|
Conversion
|
Physical Description
Colorless to light-tan crystals with a mild, chemical odor. [insecticide]
|
MW: 380.9
|
BP: Decomposes
|
MLT: 349°F
|
Sol: 0.02%
|
VP(77°F): 8 x 10-7 mmHg
|
IP: ?
|
|
Sp.Gr: 1.75
|
Fl.P: NA
|
UEL: NA
|
LEL: NA
|
|
|
Noncombustible Solid
|
Incompatibilities & Reactivities
Strong oxidizers, active metals such as sodium, strong acids, phenols
|
Measurement Methods
NIOSH S283 (II-3)
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated/Daily
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Headache, dizziness; nausea, vomiting, malaise (vague feeling of discomfort), sweating; myoclonic limb jerks; clonic, tonic convulsions; coma; [potential occupational carcinogen]; in animals: liver, kidney damage
|
Target Organs
central nervous system, liver, kidneys, skin
Cancer Site
[in animals: lung, liver, thyroid & adrenal gland tumors]
|
|
See also: INTRODUCTION
See ICSC CARD: 0787 See MEDICAL TESTS: 0077
|
|
